Nanyang Biologics to Exhibit at NVIDIA GTC 2026

Nanyang Biologics is pleased to announce that we will be exhibiting at NVIDIA GTC 2026, taking place from March 16–19, 2026.

‍

As one of the world’s leading conferences on accelerated computing and AI infrastructure, NVIDIA GTC brings together pioneers across technology, life sciences, and enterprise innovation. This year, Nanyang Biologics will showcase how AI-native systems are transforming molecular discovery.

‍

“Guided by Nature. Powered by AI.

An End-to-End Platform for Molecular Discovery”

‍

At GTC 2026, we will present our integrated discovery architecture that connects curated natural compound intelligence with advanced graph neural network modeling and real-world validation workflows.

‍

Our platform is designed to enable scalable, decision-ready discovery across pharmaceutical research, biotechnology, consumer health, and advanced R&D environments.

‍

What to Expect at Booth #177

Visitors to our booth will have the opportunity to:

‍

Meet the Team

Engage with our scientists and AI engineers, including winners of SuperAI Genesis and members of the NVIDIA Inception ecosystem. Nanyang Biologics is also part of a global alliance with NVIDIA, HPE, and Equinix, supporting enterprise-scale AI deployment for life sciences.

‍

Discover the Architecture

Learn how our graph neural network engine, DTIGN, integrates with AI-curated natural compound intelligence to power scalable molecular discovery. We will share insights into how structured data, prediction models, and validation workflows connect within a unified system.

‍

Discuss Real-World Applications

Explore use cases ranging from early-stage compound screening to enterprise AI deployment across biotech, consumer health, and advanced research organizations.

‍

Explore Collaboration Pathways

Whether you are evaluating a pilot program, assessing an industry-specific use case, or considering a long-term AI discovery partnership, our team will be available to discuss strategic alignment and next steps.

‍

From Theory to Deployment

We believe NVIDIA GTC 2026 represents a critical moment where AI moves decisively from research theory into operational deployment. For life sciences, this shift requires not only powerful models, but also scalable infrastructure, validated workflows, and strong collaborative ecosystems.

‍

Nanyang Biologics is proud to contribute to that transition.

‍

We invite attendees of NVIDIA GTC 2026 to schedule a meeting in advance or visit us directly at Booth #177. Together, we can accelerate the next generation of molecular discovery.

‍

Nanyang Biologics
contact@nanyangbiologics.com
www.nanyangbiologics.com